Immunogenicity and Safety Testing of a Group B Intranasal Meningococcal Native Outer Membrane Vesicle Vaccine
The presently licensed meningococcal vaccine is a tetravalent capsular polysaccharide vaccine that induces immunity to serogroups A, C, Y, and W-135 but not to group B, which causes nearly half of the meningitis cases in the United States. The purpose of this study was to evaluate the safety and imm...
保存先:
| 出版年: | Infect Immun |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2002
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127675/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11796602/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.70.2.702-707.2002 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|